Rachel G Liao

Rachel G Liao

UNVERIFIED PROFILE

Are you Rachel G Liao?   Register this Author

Register author
Rachel G Liao

Rachel G Liao

Publications by authors named "Rachel G Liao"

Are you Rachel G Liao?   Register this Author

9Publications

443Reads

24Profile Views

BRCA1/2 Variant Data-Sharing Practices.

J Law Med Ethics 2019 Mar;47(1):88-96

Juli M. Bollinger, M.S., is a Research Associate in the Center for Medical Ethics and Health Policy at the Baylor College of Medicine and a Research Associate and Associate Faculty at the Berman Institute of Bioethics at Johns Hopkins University. Abhi Sanka is a Science Policy Fellow at the Science and Technology Policy Institute. He was formerly a Research Associate at the School for the Future of Innovation in Society at Arizona State University. Lena Dolman, M.S., is currently a medical student at McMaster University, Hamilton, Ontario, Canada. She was formerly a manager of Strategy and Outreach, as well as manager of the Clinical & Phenotypic Data Capture Work Stream, for the Global Alliance for Genomics and Health. Rachel G. Liao, Ph.D., is a Scientific Advisor to the Director at the Broad Institute of MIT and Harvard. She was formerly a manager for the Global Alliance for Genomics and Health, where she led the successful launch and growth of the BRCA Challenge project and its foundational product, the BRCA Exchange. Robert Cook-Deegan, M.D., is a Professor in the School for the Future of Innovation in Society at Arizona State University. He is a physician and molecular biologist who turned to policy and then entered academe through Georgetown, Stanford, and Duke Universities before joining ASU.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1073110519840487DOI Listing
March 2019

A Loss-of-Function Splice Acceptor Variant in Is Protective for Type 2 Diabetes.

Diabetes 2017 11 24;66(11):2903-2914. Epub 2017 Aug 24.

Broad Metabolism Program and Program in Medical and Population Genetics, Broad Institute, Cambridge, MA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/db17-0187DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652606PMC
November 2017

Kinase domain activation of FGFR2 yields high-grade lung adenocarcinoma sensitive to a Pan-FGFR inhibitor in a mouse model of NSCLC.

Cancer Res 2014 Sep 17;74(17):4676-84. Epub 2014 Jul 17.

Department of Medicine, Dana Farber Cancer Institute, Boston, Massachusetts. Harvard Medical School, Boston, Massachusetts. Ludwig Institute for Cancer, Cambridge, Massachusetts. Belfer Institute for Applied Cancer Science, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-13-3218DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154986PMC
September 2014

Targeted therapy for squamous cell lung cancer.

Lung Cancer Manag 2012 Dec;1(4):293-300

Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA ; Cancer Program, Broad Institute, Cambridge, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/lmt.12.40DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744181PMC
December 2012